4/A

FORM 4/A SUBMISSION

Company: RECURSION PHARMACEUTICALS, INC.
Filed: April 28, 2023
Period of Report: February 4, 2022
Accession Number: 0001209191-23-026036

View Document ↗ View on SEC.gov ↗